In human tumors, high expression of SLC7A11 can dampen ferroptosis and diminish the inhibition of tumor growth in xenograft models by acetylation-defective mutant p53 (K117R; K161R; K162R encoding the so-called p53 3KR) [8]. The gene discussed is TP53; the disease is neoplasm.